Relapsed Gray Zone Lymphoma: A Rare Clinical Challenge

被引:0
|
作者
Chhabra, Pratyaksh [1 ]
Sahu, Prerna [1 ]
Deshmukh, Ishaan M. [1 ]
Sharma, Prakriti [1 ]
Madke, Bhushan [2 ]
机构
[1] Datta Meghe Inst Higher Educ & Res, Jawaharlal Nehru Med Coll, Pathol, Wardha, India
[2] Datta Meghe Inst Higher Educ & Res, Jawaharlal Nehru Med Coll, Dermatol Venereol & Leprosy, Wardha, India
关键词
hodgkin lymphoma; chemotherapy-related toxicity; adjuvant radiation therapy; diffuse large b lymphoma; gray zone lymphoma; FEATURES INTERMEDIATE; HODGKIN;
D O I
10.7759/cureus.65592
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gray zone lymphoma (GZL) is an extremely uncommon hematological cancer with characteristics in common with both classical Hodgkin's lymphoma (HL) and diffuse large B-cell lymphoma. In this case report, we present a rare case of a 22-year-old male who developed HL initially and then transitioned to relapsed or refractory GZL. The disease relapsed twice throughout, even after the peripheral blood stem cell transplant. The initial biopsy suggested it was classical HL, and the biopsy was done late in the progression of the disease; the features suggested it was GZL. The treatment consisted of curative and preventive chemotherapy, radiation therapy, and immunotherapy.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Gray zone lymphomas: a biological experiment, and a challenge for diagnosis and management
    Eberle, Franziska C.
    Jaffe, Elaine S.
    ANNALS OF ONCOLOGY, 2011, 22 : 64 - 66
  • [42] Evaluating ibrutinib for the treatment of relapsed/refractory marginal zone lymphoma
    Cavalloni, Chiara
    Varettoni, Marzia
    Rattotti, Sara
    Arcaini, Luca
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (13) : 1643 - 1649
  • [43] Management of relapsed/refractory marginal zone lymphoma: focus on ibrutinib
    Denlinger, Nathan M.
    Epperla, Narendranath
    William, Basem M.
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 615 - 624
  • [44] Sustained response to lenalidomide for early relapsed marginal zone lymphoma
    Ibrahimi, Sami
    Vidal, Gabriel
    Mukherjee, Sarbajit
    Alhyari, Laith
    Scordino, Teresa
    Cherry, Mohamad
    BLOOD CELLS MOLECULES AND DISEASES, 2018, 71 : 53 - 54
  • [45] Grey Zone Lymphoma in the Lungs: A Rare Presentation
    Zakri, D.
    Saracino, V.
    Hughes, C. W.
    Kousha, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [46] Gray zone lymphoma: A case report and comprehensive review of literature
    Uczkowski, Dariusz
    Ashraf, Hamza
    Cherry, Mohamad
    Dimov, Nikolay
    LEUKEMIA RESEARCH REPORTS, 2023, 19
  • [47] Primary Mediastinal Gray Zone Lymphoma in an Immunocompetent Young Adult
    Wirdah, Aisyah
    Andayani, Yenny Dian
    Syahrir, Mediarty
    Djamaludin, Norman
    Murti, Krisna
    Abidin, Ali Zainal
    ACTA MEDICA INDONESIANA, 2023, 55 (03) : 350 - 352
  • [48] Successful Treatment of a Gray Zone Lymphoma With Immunotherapy: A Case Report
    Haidar, Nour A.
    Vaillant, Willy
    Salignon, Karine
    Jounblat, Youssef
    Borel, Cecile
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S459 - S459
  • [49] Mediastinal Gray-Zone Lymphoma: Still an Open Issue
    Pileri, Stefano
    Tabanelli, Valentina
    Chiarle, Roberto
    Calleri, Angelica
    Melle, Federica
    Motta, Giovanna
    Sapienza, Maria Rosaria
    Sabattini, Elena
    Zinzani, Pier Luigi
    Derenzini, Enrico
    HEMATO, 2023, 4 (03): : 196 - 206
  • [50] Impact of an Extended Use of Immunohistochemistry in Mediastinal Gray Zone Lymphoma
    Verma, Anuj
    Shet, Tanuja
    Epari, Sridhar
    Sengar, Manju
    Laskar, Siddharath
    Menon, Hari
    Banavali, Shripad
    LABORATORY INVESTIGATION, 2015, 95 : 383A - 383A